Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04042558 |
|---|---|
| Brief Title: | A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies (GFPC 06-2018) |
| First Submitted : | July 29, 2019 |
| First Submitted that Met QC Criteria : | August 1, 2019 |
| First Posted : | August 2, 2019 |
| Last Update Submitted that Met QC Criteria : | July 31, 2023 |
| Last Update Posted : | August 1, 2023 |